Sign In
Pricing

2022
Exports $507MWorld Rnk 49 / 223
Flag Rnk 39 / 96
2022
Destination $39.2M Singapore
2021 - 2022
FASTEST GROWING MARKET $39.2MSingapore
2022
PRODUCT COMPLEXITY IN Pharmaceutical products1.38Rnk 75 / 1025
2022
Imports $2.07BWorld Rnk 49 / 226
Flag Rnk 23 / 96
2022
Origin $35.7M Germany
2021 - 2022
FASTEST GROWING ORIGIN $35.7MSwitzerland
2022
ECONOMIC COMPLEXITY of Malaysia1.09Rnk 24 / 133

About

Exports In 2022, Malaysia exported $507M in Pharmaceutical products, making it the 49th largest exporter of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 39th most exported product in Malaysia. The main destination of Pharmaceutical products exports from Malaysia are: Singapore ($98.5M), United States ($98.3M), Brunei ($50.4M), Hong Kong ($29.1M), and Australia ($26.6M).

The fastest growing export markets for Pharmaceutical products of Malaysia between 2021 and 2022 were Singapore ($39.2M), United States ($28.8M), and Saudi Arabia ($6.26M).

Imports In 2022, Malaysia imported $2.07B in Pharmaceutical products, becoming the 49th largest importer of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 23rd most imported product in Malaysia. Malaysia imports Pharmaceutical products primarily from: Germany ($332M), Switzerland ($240M), China ($211M), Singapore ($140M), and Belgium ($124M).

The fastest growing import markets in Pharmaceutical products for Malaysia between 2021 and 2022 were Switzerland ($35.7M), India ($29.1M), and Ireland ($28.7M).

COMPANIES In 2023, leading companies such as Tesla (2) were at the forefront of shipping Pharmaceutical products from Malaysia to the United States.

Latest Trends

September 2024

About

Overview In September 2024 Malaysia's Pharmaceutical products exports accounted up to MYR176M and imports accounted up to MYR957M, resulting in a negative trade balance of MYR781M. Between September 2023 and September 2024 the exports of Malaysia's   Pharmaceutical products have decreased by MYR-43.4M (-19.7%) from MYR220M to MYR176M, while imports increased by MYR126M (15.2%) from MYR831M to MYR957M.

Destinations In September 2024, Pharmaceutical products were exported mostly to United States (MYR41M), Singapore (MYR23M), Brunei (MYR15.5M), Australia (MYR12.9M), and Hong Kong (MYR11.9M), and were imported mostly from Germany (MYR189M), United States (MYR93.3M), Singapore (MYR69.9M), Switzerland (MYR69.1M), and France (MYR62.3M).

Growth In September 2024, the decrease in Pharmaceutical products's year-by-year exports was explained primarily by a decrease in exports to United States (MYR-36M or -92.8%), Australia (MYR-8.07M or -33%), and Cambodia (MYR-5.42M or -93.9%). In September 2024, the increase in Pharmaceutical products's year-by-year imports was explained primarily by an increase in imports from United States (MYR29.6M or 46.7%), India (MYR27.1M or 91.7%), and Italy (MYR26.6M or 163%).

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (September 2023 - September 2024)MYR-43.4M(-19.7%)
IMPORT GROWTH (September 2023 - September 2024)MYR126M(15.2%)
MAIN DESTINATION (September 2024)United StatesMYR41M

This section shows Pharmaceutical products's exports and imports data at subnational level for Malaysia. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Pharmaceutical products over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$507M
IMPORTS (2022)$2.07B
NET TRADE (2022)-$1.56B

In 2022, Malaysia exported $507M in Pharmaceutical products. The main destinations of Malaysia exports on Pharmaceutical products were Singapore ($98.5M), United States ($98.3M), Brunei ($50.4M), Hong Kong ($29.1M), and Australia ($26.6M).

In 2022, Malaysia imported $2.07B in Pharmaceutical products, mainly from Germany ($332M), Switzerland ($240M), China ($211M), Singapore ($140M), and Belgium ($124M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Pharmaceutical products EXPORT MARKETS FOR Malaysia WERE (2021 - 2022):
Singapore$39.2M (66.2%)
United States$28.8M (41.5%)
Saudi Arabia$6.26M (499%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Pharmaceutical products BY Malaysia WERE (2021 - 2022):
Brunei-$23.4M (-31.7%)
Australia-$11.4M (-30%)
Netherlands-$4.71M (-82.2%)
Explore Visualizations

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Malaysia's main exporting competitors in Pharmaceutical products were:
Germany $125B
Switzerland $93.8B
United States $90B
In 2022, Malaysia's main importing competitors in Pharmaceutical products were:
United States $168B
Germany $71.1B
Switzerland $48.5B

Explore Visualizations

Trade Value of Pharmaceutical products by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $80.8M
TOP IMPORT POTENTIALGermany+ $117M

Pharmaceutical products’s highest export potential is United States. With an export gap of $80.8M.   Pharmaceutical products’s highest import potential is Germany with an import gap of $117M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms